Anatolii Zagorodnii
Anatolii works in Business Development at BioPharmaTrend, supporting commercial partnerships while also contributing to editorial content and event coverage across immuno-oncology and de-novo protein design topics. Trained as an immuno-oncologist (MSc from University of Oxford; BSc from UCL), he combines strong scientific grounding with hands-on experience operating in the early-stage biotech startups within the UK’s rapidly growing life-sciences ecosystem.


